Are Synthetic Cannabinoids (K2 / Spice) legal in Switzerland?

Legal status

Not applicable as a class status, because Switzerland controls these compounds one at a time and by defined family. The source row records „JWH-018; AB-CHMINACA; weitere einzeln benannte oder von Verzeichnis e erfasste Stoffe“, individually named compounds together with further substances caught by list e. List e is broad only where its own defined families apply, and BetmVV-EDI article 1 makes the control set closed, so a compound that is neither named nor inside a defined family is not controlled merely because it acts on the same receptors. A product sold as a synthetic cannabinoid can therefore fall inside or outside the ordinance depending on the exact compound, which is why no single terminal status is stated here.

Consequences if caught

Capital exposure: none. Switzerland has no death penalty, and beyond that no single ceiling can be stated for the label, because the label does not identify a substance. A named compound such as JWH-018 or AB-CHMINACA, or one caught by a defined family in list e, engages BetmG article 19, with the aggravated forms in article 19(2) and the 20 year maximum supplied by StGB article 40. The 20 year maximum that StGB article 40 supplies for a BetmG article 19 offence therefore attaches to a constituent and never to the name on the packet. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.

If prescribed or medical

The personal use regime in BetmG articles 19a and 19b is the country level rule this dossier establishes, and article 19b(2) fixes its only stated quantity at 10 g of cannabis, a figure that belongs to the cannabis entries and not to these compounds. The class has no schedule placement of its own to attach that rule to, because placement follows the individual compound, either as a named entry or through a defined family in list e. No synthetic cannabinoid has an authorised medical form or a prescription route on the facts recorded in this dossier.

Documentation

Carry no product sold as a synthetic cannabinoid on the assumption that this row clears it, because the row records a class that resolves compound by compound. The provenance is BetmVV-EDI article 1 and list e in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the individually named examples „JWH-018; AB-CHMINACA“ recorded by the source; the not applicable treatment is kept here because a class defined by its effect cannot share one Swiss classification.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Switzerland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.